Qiagen NV

NYSE: QGEN
$42.33
+$0.24 (+0.6%)
Closing Price on November 21, 2024

QGEN Stock Chart and Intraday Price

QGEN Stock Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address HULSTERWEG 82, PL VENLO, NL
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 9,617.09M USD
Shares Outstanding 221,337,000
Qiagen NV is a global leader in providing comprehensive solutions that convert biological materials into valuable molecular insights. Founded in 1986 and based in Venlo, the Netherlands, Qiagen serves a wide range of customers in molecular diagnostics, academia, pharmaceuticals, and applied testing. The company's offerings include a variety of consumables and instruments for nucleic acid purification, genotyping, gene expression analysis, and more. Qiagen also specializes in assays for a range of applications, from prenatal testing to infectious disease detection and forensic analysis, complemented by powerful bioinformatics solutions.

QGEN Articles

Wednesday's top analyst upgrades and downgrades included CVS Health, DataDog, Endeavor, Enphase Energy, Extreme Networks, GitLab, Nvidia, RTX, Splunk and United Parcel Service.
Tuesday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, Bill.com, Boeing, Costco, Dicks Sporting Goods, Generac, Proofpoint, Regeneron Pharmaceuticals and Shopify.
Thursday's top analyst upgrades and downgrades included BioMarin Pharmaceuticals, Checkpoint Software Technologies, Cinemark, Fortinet, Palo Alto Networks, Regeneron Pharmaceuticals, Shake Shack,...
The top analyst upgrades, downgrades and initiations seen on Tuesday included AFL, Agilent, Allergan, Barrick Gold, Cognex, Hilton, Lloyds, MetLife, Slack and Wingstop.
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Brocade Communications Systems, Facebook, First Solar, Fitbit, ONEOK Partners and Sunrun.
Thursday's top analyst upgrades, downgrades and initiations include AMAG Pharmaceuticals, Devon Energy, eBay, Freshpet, Range Resources, Raytheon, SeaWorld and Zynga.
A new report from Cowen makes the case that a blood test that detects evidence of cancer in the circulation could soon replace the older more traditional biopsy methods.
The following companies were featured in a new Leerink report on understand testing trends for sexually transmitted diseases.
U.S. equity markets opened slightly higher this morning following the report on U.S. jobless numbers (more coverage here). In Europe, the only data out today showed that U.K. retail sales fell 0.7%,...
Jon OggWhile investors generally see analysts issuing Buy ratings, it is always interesting to see what happens when Wall St. analysts give stocks to sell or when they have very cautious comments...
Thinkstock24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the sector...
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Monday. Apple Inc. (NASDAQ: AAPL) cut to Neutral and target cut to $575 from $675 at...
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning. Amazon.com Inc. (NASDAQ: AMZN) Started as Neutral at Collins...
There are many stocks on the move for day traders and active traders to pick from this Tuesday morning.  We are watching the key moves in AgFeed Industries, Inc. (NASDAQ: FEED), Ambac Financial...
These are this Thursday’s early bird analyst downgrades and negative research calls with more than two hours until the market opens: ASML (ASML) Cut to Neutral at B of A Merrill Lynch. GSI Commerce...